doi:10.1016/j.bmcl.2006.08.045
Copyright © 2006 Elsevier Ltd All rights reserved.
Syntheses and studies of quinolone-cephalosporins as potential anti-tuberculosis agents
Gaiying Zhaoa, Marvin J. Millera,
,
, Scott Franzblaub, Baojie Wanb and Ute Möllmannc
aDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, USA
bInstitute for Tuberculosis Research, College of Pharmacy, M/C 964, Rm 412, University of Illinois at Chicago, 833 S. Wood St., Chicago, IL 60612-7231, USA
cLeibniz Institute for Natural Product Research and Infection Biology, Hans-Knöll-Institute, Beutenbergstrasse 11a, D-07745 Jena, Germany
Received 21 June 2006;
revised 6 August 2006;
accepted 8 August 2006.
Available online 30 August 2006.
References and further reading may be available for this article. To view references and further reading you must
purchase this article.
Abstract
The syntheses and anti-tuberculosis activity of quinolone-cephalosporin conjugates (1 and 2) are described. Both showed broad-spectrum antibacterial activity and significant anti-TB activity. The carbamate-linked quinolone-cephem 2 showed better antimycobacterial activity, including anti-TB activity, than the direct amine-linked quinolone-cephem 1, while quinolone-cephem 1 was slightly more effective against some Gram-negative bacterial strains.
Keywords: Anti-tuberculosis; Antibacterial agents; Quinolonyl-β-lactams
Figure 1. QLAs: quinolone-cephalosporine conjugates.
Scheme 1. Procedure for synthesis of amine-linked quinolone-cephalosporin conjugate.
Scheme 2. Procedure for synthesis of carbamate-linked quinolone-cephalosporin conjugate.
Table 1.
Antibacterial activity of quinolone-cephalosporin compounds
a Ciprofloxacin from BioChemika.
b MABA, microplate alamar blue assay.
15c GAS, glycerol-alanine-salts.
16d Concentration resulting in 50% inhibition of the growth of VERO cells.
17e NT, not tested.